Abaxis gets FDA clearance for CRP test

01/21/2010 | ABC News

Abaxis, a provider of blood analysis systems, said it has obtained an FDA marketing clearance for its C-Reactive Protein assay. The test, which complements the company's Piccolo Xpress system, can detect infections, inflammatory diseases, tissue injuries and abnormal cell growth in under 12 minutes, Abaxis said.

View Full Article in:

ABC News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC